Date Field | Doc. No. | Party | Description |
---|
Aug 4, 2017 | 1005 | | RESERVED Download |
Aug 4, 2017 | 1042 | | Prosecution History for U.S. Patent No. 8,329,680 (downloaded from PAIR) Download |
Aug 4, 2017 | 1021 | | Faslodex Label Download |
Aug 4, 2017 | 1003 | | RESERVED Download |
Aug 4, 2017 | 1071 | | Smith, Analysis of Oil-Based Pharmaceuticals, 49 J. AMERICAN OIL CHEMISTS' SOCIETY 409-13 (1972) Download |
Aug 4, 2017 | 1004 | | RESERVED Download |
Aug 4, 2017 | 1040 | | Alan E. Wakeling & Jean Bowler, ICI 182,780: A New Antioestrogen with Clinical Potential, 43 J. STEROID BIOCHEM. MOLEC. BIOL. 173-177 (1992) Download |
Aug 4, 2017 | 1010 | | Order, AstraZeneca Pharms. LP v. Sandoz Inc., No. 14-03547 (D.N.J. July 29, 2015), ECF No. 102 Download |
Aug 4, 2017 | 1023 | | Qiu, Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice (2009) Download |
Aug 4, 2017 | 1037 | | WO 03 006064 Download |
Aug 4, 2017 | 1057 | | Dukes, Antiuterotrophic Effects of the Pure Antioestrogen ICI 182,780 in Adult Female Monkeys (Macaca nemestrina): Quantitative Magnetic Resonance Imaging, 138 J. ENDOCRINOLOGY 203-09 (1993) Download |
Aug 4, 2017 | 1063 | | Equivalent Surface Area Dosage Conversion Factors (2007) Download |
Aug 4, 2017 | 1073 | | Taucher, Sequential Steroid Hormone Receptor Measurements in Primary Breast Cancer with or without Intervening Primary Chemotherapy, 10 ENDOCRINE-RELATED CANCER 91-98 (2003) Download |
Aug 4, 2017 | 1066 | | Johnston, Changes in Estrogen Receptor, Progesterone Receptor, and pS2 Expression in Tamoxifen-Resistant Human Breast Cancer, 55 CANCER RESEARCH 3331-38 (1995) Download |
Aug 4, 2017 | 1017 | | AstraZeneca's Preliminary Response in Mylan Pharms. Inc. v. AstraZeneca AB, Paper No. 10, IPR2016-01325 (P.T.A.B. Oct. 6, 2016) Download |
Aug 4, 2017 | 1030 | | White, Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization, 57 ANTIMICROBIAL AGENTS & CHEMOTHERAPY 5802 (2013) Download |
Aug 4, 2017 | 1054 | | Santen, Use of Aromatase Inhibitors in Breast Carcinoma, 6 ENDOCRINE-RELATED CANCER 75-92 (1999) Download |
Aug 4, 2017 | 1049 | | Anderson, Models of New Antioestrogen Action in Vivo: Primary Tumours, 5 THE BREAST 186-91 (1996) Download |
Aug 4, 2017 | 1059 | | Selective Estrogen Receptor Modulators (SERMs), BREASTCANCER.ORG (last modified Nov. 5, 2015), http://www.breastcancer.org/treatment/hormonal/serms Download |
Aug 4, 2017 | 1035 | | Uges, Plasma or Serum in Therapeutic Drug Monitoring and Clinical Toxicology, 10 PHARMACEUTISCH WEEKBLAD SCIENTIFIC EDITION 185-88 (1988) Download |
Aug 4, 2017 | 1056 | | Howell, Response to a Specific Antioestrogen (ICI 182780) in Tamoxifen-Resistant Breast Cancer, 345 LANCET 29-30 (1995) Download |
Aug 4, 2017 | 1068 | | Mackey, Tolerability of Intramuscular Injections of Testosterone Ester in Oil Vehicle, 10 HUMAN REPRODUCTION 862-65 (1995) Download |
Aug 4, 2017 | 1009 | | O'Regan et al., Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth, 90 J. NATL CANCER INST. 1552-1558 (1998) Download |
Aug 4, 2017 | 1033 | | Riffkin, Castor Oil as a Vehicle for Parenteral Administration of Steroid Hormones, 53 J. PHARM. SCI. 891-895 (1964) Download |
Aug 4, 2017 | 1069 | | Kern, "Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype," Endocrinology of Breast Cancer 169-86 (Manni ed., 1999) Download |
Aug 4, 2017 | 1061 | | Thomas, The Effects of ICI 182,780, a Pure Anti-Oestrogen, on the Hypothalamic-Pituitary-Gonadal Axis and on Endometrial Proliferation in Pre-Menopausal Women, 9 HUMAN REPRODUCTION 1991-96 (1994) Download |
Aug 4, 2017 | 1024 | | Tozer, Introduction to Pharmacokinetics and Pharmacodynamics: The Quantitative Basis of Drug Therapy (2006) Download |
Aug 4, 2017 | 1012 | | Declaration of Diane Burgess, Ph.D. and Accompanying Exhibits Download |
Aug 4, 2017 | 1045 | | Howell, Response to a Specific Antioestrogen (ICI 182780) in Tamoxifen-Resistant Breast Cancer, 345 LANCET 989-90 (1995) Download |
Aug 4, 2017 | 1026 | | Wills, "Basic Pharmacodynamic Concepts and Models," Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology (1994) Download |
Aug 4, 2017 | 1008 | | McLeskey et al., Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors, 4 CLIN. CANCER RESEARCH 697-711 (1998) Download |
Aug 4, 2017 | 1019 | | Declaration Under 37 C.F.R. 1.132 of Ronald J. Sawchuk in Application No. 12 285,887 Download |
Aug 4, 2017 | 1022 | | DiPiro, Concepts in Clinical Pharmacokinetics (2010) Download |
Aug 4, 2017 | 1046 | | Prosecution History for the U.S. Patent No. 7,456,160 Download |
Aug 4, 2017 | 1001 | | U.S. Patent No. 8,466,139 Download |
Aug 4, 2017 | 1011 | | Institution Decision in Mylan Pharms. Inc. v. AstraZeneca AB, Paper No. 11, IPR2016-01325 (P.T.A.B. Dec. 14, 2016) Download |
Aug 4, 2017 | 1007 | | Howell et al., Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer, 74 BRIT. J. CANCER 300-08 (1996) Download |
Aug 4, 2017 | 1064 | | Clarke, Antiestrogen Resistance in Breast Cancer and the Role of Estrogen Receptor Signaling, 22 ONCOGENE 7316-39 (2003) Download |
Aug 4, 2017 | 1038 | | DeFriend et al., Investigation of a New Pure Antiestrogen (ICI 182780) in Women with Primary Breast Cancer, 54 CANCER RESEARCH 408-414 (1994) Download |
Aug 4, 2017 | 1027 | | Derendorf, Handbook of Pharmacokinetic Pharmacodynamic Correlation 53 (1995) Download |
Aug 4, 2017 | 1020 | | Declaration Under 37 C.F.R. 1.132 of Paul Richard Gellert in Application No. 10 872,784 Download |
Aug 4, 2017 | 1074 | | Turner, Administration of Substances to Laboratory Animals: Routes of Administration and Factors to Consider, 50 J. AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE 600-13 (2011) Download |
Aug 4, 2017 | 1058 | | Wakeling, The Future of New Pure Antioestrogens in Clinical Breast Cancer, 25 BREAST CANCER RESEARCH & TREATMENT 1-9 (1993) Download |
Aug 4, 2017 | 1052 | | Howell, The Definition of the 'No Change' Category in Patients Treated with Endocrine Therapy and Chemotherapy for Advanced Carcinoma of the Breast, 24 EUR. J. CANCER CLIN. ONCOL. 1567-72 (1988) Download |
Aug 4, 2017 | 1055 | | EP 0 346 014 Download |
Aug 4, 2017 | 1062 | | Freireich, Quantitative Comparison of Toxicity of Anticancer Agents in Mouse, Rat, Hamster, Dog, Monkey, and Man, 50 CANCER CHEMOTHERAPY REPORTS 219-44 (1966) Download |
Aug 4, 2017 | 1 | | PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 8,466,139 UNDER 35 U.S.C. 311-319 AND 37 C.F.R. 42.100 ET SEQ. Download |
Aug 4, 2017 | 1051 | | Howell, New Endocrine Therapies for Breast Cancer, 32A EUR. J. CANCER 576-88 (1996) Download |
Aug 4, 2017 | 1014 | | Declaration of Dorraya El Ashry, Ph.D. and Accompanying Exhibits Download |
Aug 4, 2017 | 1029 | | Colburn, Simultaneous Pharmacokinetic Pharmacodynamic Modeling, PHARMACODYNAMICS AND DRUG DEVELOPMENT: PERSPECTIVES IN CLINICAL PHARMACOLOGY (1994) Download |
Aug 4, 2017 | 1039 | | Osborne et al., Comparison of the Effects of a Pure Steroidal Antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer, 87 J. NATL CANCER INST. 746-750 (1995) Download |
Aug 4, 2017 | 1072 | | Spiegel & Noseworthy, Use of Nonaqueous Solvents in Parenteral Products, 52 J. PHARM. SCIS. 917-27 (1963) Download |
Aug 4, 2017 | 1044 | | Robertson, Fulvestrant Versus Anastrozole for the Treatment of Advanced Breast Carcinoma in Postmenopausal Women: A Prospective Combined Analysis of Two Multicenter Trials, 98 CANCER 229-38 (2003) Download |
Aug 4, 2017 | 1015 | | Declaration of Adrian Harris, Ph.D. and Accompanying Exhibits Download |
Aug 4, 2017 | 1041 | | Howell, A. et al., Clinical Studies With The Specific 'Pure' Antiestrogen ICI 182780, THE BREAST, Vol. 5:192-195 (1996) Download |
Aug 4, 2017 | 1043 | | Robertson, J.F.R. et al., Duration Of Remission To ICI 182,780 Compared To Megestrol Acetate In Tamoxifen Resistant Breast Cancer, THE BREAST, Vol. 6:186-189 (1997) Download |
Aug 4, 2017 | 1013 | | Declaration of Richard Bergstrom, Ph.D. and Accompanying Exhibits Download |
Aug 4, 2017 | 1048 | | Parczyk, K. et al., Progesterone Receptor Repression by Estrogens in Rat Uterine Epithelial Cells, 63 J. STEROID BIOCHEMISTRY & MOLECULAR BIOLOGY 309 (1997) Download |
Aug 4, 2017 | 1070 | | Neubauer, Changes in Tumour Biological Markers during Primary Systemic Chemotherapy (PST), 28 ANTICANCER RESEARCH 1797-804 (2008) Download |
Aug 4, 2017 | 1036 | | Dukes et al., Antiuterotrophic effects of a pure antioestrogen, ICI 182,780: magnetic resonance imaging of the uterus in ovariectomized monkeys, 135 J. ENDOCRINOLOGY 239-247 (1992) Download |
Aug 4, 2017 | 1067 | | Waynforth, LASA Good Practice Guidelines: Administration of Substances (Rat, Mouse, Guinea Pig, Rabbit) (Oct. 1998), www.procedureswithcare.org.uk/lasa_administration.pdf Download |
Aug 4, 2017 | 1025 | | Caldwell, An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and Excretion, 23 Toxicologic Pathology 102 (1995) Download |
Aug 4, 2017 | 1060 | | Howell, Fulvestrant Revisited: Efficacy and Safety of the 500-mg Dose, 11 CLINICAL BREAST CANCER 204-10 (2011) Download |
Aug 4, 2017 | 1006 | | Prosecution History for U.S. Patent No. 6,774,122 Download |
Aug 4, 2017 | 1031 | | Wakeling et al., A Potent Specific Pure Antiestrogen with Clinical Potential, 51 CANCER RESEARCH 3867-3873 (1991) Download |
Aug 4, 2017 | 1065 | | Gusterson, Do we now have a relevant animal model for breast cancer? 1 BREAST CANCER RESEARCH 2-4 (1999) Download |
Aug 4, 2017 | 1002 | | RESERVED Download |
Aug 4, 2017 | 1028 | | Mager, Scaling Pharmacodynamics from In Vitro and Preclinical Animal Studies to Humans, DRUG METAB. PHARMACOKINET. (2009) Download |
Aug 4, 2017 | 1018 | | DeLuca, Formulation of Small Volume Parenterals, PHARMACEUTICAL DOSAGE FORMS: PARENTERAL MEDICATIONS VOLUME 1 (Avis ed., 2d ed. 1992) Download |
Aug 4, 2017 | 1047 | | U.S. Patent No. 5,183,814 Download |
Aug 4, 2017 | 1034 | | Finley, New Drug Being Tested in Breast Cancer Study, SAN ANTONIO EXPRESS-NEWS, Sept. 20, 1997 Download |
Aug 4, 2017 | 1053 | | Nicholson, "Pure Antioestrogens in Breast Cancer: Experimental and Clinical Observations," Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects, Proceedings of an International Symposium, Milano 347-60 (1994) Download |
Aug 4, 2017 | 1016 | | U.S. Patent No. 4,659,516 Download |
Aug 4, 2017 | 1050 | | Buzdar, Update on Endocrine Therapy for Breast Cancer, 4 CLINICAL CANCER RESEARCH 527-34 (1998) Download |
Aug 4, 2017 | 1032 | | Nicholson, R.I. et al., Responses To Pure Antiestrogens (ICI 164384, ICI 82780) In Estrogen-Sensitive And - Resistant Experimental And Clinical Breast Cancer, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 61:148-163 (1995) Download |
Aug 4, 2017 | 1107 | | Roberts, Investigation of Cosolvent Effects on the Solvation of AOT Reverse Micelles in Supercritical Ethane, 102 J. PHYS. CHEM. B 9074-80 (1998) Download |
Aug 4, 2017 | 1097 | | Balant-Gorgia, Pharmacokinetic Optimisation of the Treatment of Psychosis, 25 CLIN. PHARMACOKINET. 217-36 (1993) Download |
Aug 4, 2017 | 1087 | | Prosecution History for the U.S. Patent No. 8,466,139 Download |
Aug 4, 2017 | 1088 | | Wunsche, Estrogenic Regulation of Clusterin mRNA in Normal and Malignant Endometrial Tissue, 76 INT. J. CANCER 684-88 (1998) Download |
Aug 4, 2017 | 1079 | | Handbook of Pharmaceutical Excipients (Wade ed., 2d. ed. 1994) Download |
Aug 4, 2017 | 1102 | | Nema, Excipients and Their Use in Injectable Products, 51 PDA J. PHARM. SCI. & TECH. 166-71 (1997) Download |
Aug 4, 2017 | 1092 | | Lee, Standard Deviation and Standard Error of the Mean, 68 KOREAN J. ANESTHESIOLOGY 220-23 (2015) Download |
Aug 4, 2017 | 1105 | | Powell, Compendium of Excipients for Parenteral Formulations, 52 PDA J. PHARM. SCI. & TECH. 238-311 (1998) Download |
Aug 4, 2017 | 1096 | | August 21, 2008 Applicant Amendment and Response in Application No. 10 872,784 Download |
Aug 4, 2017 | 1110 | | Ting, Solubility of Naproxen in Supercritical Carbon Dioxide with and without Cosolvents, 32 IND. ENG. CHEM. RES. 1471-81 (1993) Download |
Aug 4, 2017 | 1078 | | Petition for Inter Partes Review in Mylan Pharms. Inc. v. AstraZeneca AB, Paper No. 2, IPR2016-01326 (P.T.A.B. June 29, 2016) Download |
Aug 4, 2017 | 2 | | PETITIONER FRESENIUS KABI'S POWER OF ATTORNEY, U.S. PATENT NO. 8,466,139 Download |
Aug 4, 2017 | 1094 | | Tse, Bioavailability of Parenteral Drugs I. Intravenous and Intramuscular Doses, 34 J. PARENTERAL DRUG ASSOCIATION 409-21 (1980) Download |
Aug 4, 2017 | 1084 | | Fabian, Clinical Pharmacology of Tamoxifen in Patients with Breast Cancer: Correlation with Clinical Data, 48 CANCER 876-82 (1981) Download |
Aug 4, 2017 | 1098 | | Chien, Solubilization of Steroids by Multiple Co-Solvent Systems, 23 CHEM. PHARM. BULL. 1085-90 (1975) Download |
Aug 4, 2017 | 1111 | | Tse, Bioavailability of Parenteral Drugs II. Parenteral Doses Other Than Intravenous and Intramuscular Routes, 34 J. PARENTERAL DRUG ASSOCIATION 484-95 (1980) Download |
Aug 4, 2017 | 1103 | | Ogasawara, Effects of Experimental Chemoendocrine Therapy with a Combination of a Pure Antiestrogen and 5-Fluorouracil on Human Breast Cancer Cells Implanted in Nude Mice, 29 SURGERY TODAY 149-56 (1999) Download |
Aug 4, 2017 | 1100 | | Cunliffe-Beamer, "Biomethodology and Surgical Techniques," The Mouse in Biomedical Research, Volume III: Normative Biology, Immunology, and Husbandry 401-37 (Foster ed., 1983) Download |
Aug 4, 2017 | 1093 | | Altman, Standard Deviations and Standard Errors, 331 BMJ 903 (2005) Download |
Aug 4, 2017 | 1075 | | Robertson, J.F.R. et al., A Partially-Blind, Randomised, Multicentre Study Comparing the Anti-Tumor Effects of Single Doses (50, 125, 250 mg) Of Long-Acting (LA) 'Faslodex' (ICI 182,780) With Tamoxifen ... (Dec. 8-11, 1999) Download |
Aug 4, 2017 | 1085 | | Goldenberg, Trastuzumab, a Recombinant DNA-Derived Humanized Monoclonal Antibody, a Novel Agent for the Treatment of Metastatic Breast Cancer, 21 CLINICAL THERAPEUTICS 309-18 (1999) Download |
Aug 4, 2017 | 1104 | | Oldham, "Mass Transport to Electrodes," Chemical Kinetics 79-143 (Bamford ed., 1986) Download |
Aug 4, 2017 | 1086 | | Wilkinson, Tamoxifen (Nolvadex*) Therapy - Rationale for Loading Dose Followed by Maintenance Dose for Patients with Metastatic Breast Cancer, 10 CANCER CHEMOTHERAPY PHARMACOLOGY 33-35 (1982) Download |
Aug 4, 2017 | 1083 | | Baselga, Phase II Study of Weekly Intravenous Recombinant Humanized Anti-p185HER2 Monoclonal Antibody in Patients with HER2/neu-Overexpressing Metastatic Breast Cancer, 14 J. CLINICAL ONCOLOGY 737-44 Download |
Aug 4, 2017 | 1080 | | FDA's Inactive Ingredient Database (1996) Download |
Aug 4, 2017 | 1112 | | U.S. Patent No. 4,212,863 Download |
Aug 4, 2017 | 1077 | | Jorgensen, Pharmacokinetic Studies in Volunteers of Intravenous and Oral Cis (Z)-Flupentixol and Intramuscular Cis (Z)-Flupentixol Decanoate in Viscoleo, 18 EUR. J. CLIN. PHARMACOL. 355-60 (1980) Download |
Aug 4, 2017 | 1089 | | Chwalisz, Modulation of Oestrogenic Effects by Progesterone Antagonists in the Rat Uterus, 4 HUMAN REPRODUCTION UPDATE 570-83 (1998) Download |
Aug 4, 2017 | 1113 | | USP 23 ¿¿¿ NF 18, The United States Pharmacopeia ¿¿¿ The National Formulary 13-14 (1995) Download |
Aug 4, 2017 | 1095 | | Licciardi, Oral Versus Intramuscular Progesterone for In Vitro Fertilization: A Prospective Randomized Study, 71 FERTILITY & STERILITY 614-18 (1999) Download |
Aug 4, 2017 | 1099 | | Ford, "Parenteral Products," Pharmaceutics: The Science of Dosage Form Design 359-80 (Aulton ed., 1988) Download |
Aug 4, 2017 | 1108 | | Sawka, Physiological Consequences of Hypohydration: Exercise Performance and Thermoregulation, 24 MEDICINE & SCIENCE IN SPORTS & EXERCISE 657-70 (1992) Download |
Aug 4, 2017 | 1091 | | Ansel, "Dosage Form Design: Biopharmaceutic and Pharmacokinetic Considerations," Pharmaceutical Dosage Forms and Drug Delivery Systems 101-41 (7th ed. 1999) Download |
Aug 4, 2017 | 1101 | | Way, "Cosolvent Use in Injectable Formulations," Injectable Drug Development: Techniques to Reduce Pain and Irritation 215-66 (Gupta ed., 1999) Download |
Aug 4, 2017 | 1109 | | Simmons, The Laboratory Mouse: Selection and Management 127-28 (1970) Download |
Aug 4, 2017 | 1081 | | Drugs FDA Glossary of Terms, U.S. FOOD & DRUG ADMINISTRATION (last updated Feb. 2, 2012) Download |
Aug 4, 2017 | 1106 | | Remington's Pharmaceutical Sciences 1538-39, 1545-50, 1686-88 (18th ed. 1990) Download |
Aug 4, 2017 | 1090 | | Robertson, Fulvestrant (Faslodex)-How to Make a Good Drug Better, 12 ONCOLOGIST 774-84 (2007) Download |
Aug 4, 2017 | 1082 | | Adam, "Pharmacokinetics of Agents in Relation to Response," Endocrine Management of Cancer: Biological Bases 112-24 (1988) Download |
Aug 4, 2017 | 1076 | | Kohler, Plasma and Tissue Concentrations Following Intramuscular Administration of Etofenamat. Pharmacokinetics of Etofenamat and Flufenamic Acid in Plasma, Synovium, and Tissues of Patients with, 42 ARZNEIMITTEL-FORSCHUNG (English Abstract) (1992) Download |
Aug 4, 2017 | 3 | | MOTION FOR JOINDER UNDER 35 U.S.C. 315(c) AND 37 C.F.R. 42.22 AND 42.122(b) Download |
Aug 16, 2017 | 4 | | Notice of Accord Filing Date Download |
Aug 25, 2017 | 6 | | Patent Owner's Mandatory Notices Pursuant to 37 C.F.R. 42.8 Download |
Aug 25, 2017 | 5 | | Patent Owner's Power of Attorney Pursuant to 37 C.F.R. 42.10(b) Download |
Nov 2, 2017 | 7 | | Order Denying Petitioner's Requests for Authorization to File a Motion to Withdraw the Petition And Motion for Joinder Download |
Nov 2, 2017 | 3001 | | Ex. 3001 Download |
Nov 16, 2017 | 2041 | | Haarstad 1992 Download |
Nov 16, 2017 | 2017 | | Jordan 1995 Download |
Nov 16, 2017 | 2040 | | Howell 1997 Download |
Nov 16, 2017 | 2160 | | Huynh 1993 Download |
Nov 16, 2017 | 2044 | | Innovative Research Download |
Nov 16, 2017 | 2152 | | Goss 1986 Download |
Nov 16, 2017 | 2037 | | Hortobagyi 1997 Download |
Nov 16, 2017 | 2136 | | Robertson Mylan Declaration Download |
Nov 16, 2017 | 2140 | | Buzdar 2001 Download |
Nov 16, 2017 | 2054 | | Beyea 1996 Download |
Nov 16, 2017 | 2027 | | Dukes 1994 Download |
Nov 16, 2017 | 2030 | | Robertson 2001 Download |
Nov 16, 2017 | 2163 | | Dipippo 1997 Download |
Nov 16, 2017 | 2039 | | Hayes 1995 Download |
Nov 16, 2017 | 2119 | | Buzdar 1996 Download |
Nov 16, 2017 | 2007 | | Pritchard 2010 Download |
Nov 16, 2017 | 2009 | | Robertson 1996 Download |
Nov 16, 2017 | 2032 | | Labrie 2004 Download |
Nov 16, 2017 | 2135 | | Illum Mylan Declaration Download |
Nov 16, 2017 | 2124 | | Huber 1965 Download |
Nov 16, 2017 | 2110 | | Lundeen 1997 Download |
Nov 16, 2017 | 2111 | | Buzdar 2003 Download |
Nov 16, 2017 | 2149 | | Abrams 1990 Download |
Nov 16, 2017 | 2014 | | Pritchard 1997 Download |
Nov 16, 2017 | 2006 | | Ohno 2010 Download |
Nov 16, 2017 | 2068 | | Baumann 1998 Download |
Nov 16, 2017 | 2105 | | Porras 1999 Download |
Nov 16, 2017 | 2008 | | Greenlee 2000 Download |
Nov 16, 2017 | 2130 | | Levine 1966 Download |
Nov 16, 2017 | 2147 | | Koyama 1999 Download |
Nov 16, 2017 | 2096 | | Ansel Ch. 12 Download |
Nov 16, 2017 | 2159 | | Martel 1998 Download |
Nov 16, 2017 | 2056 | | Robertson 2012 Download |
Nov 16, 2017 | 2108 | | Buzdar ASCO 2001 Download |
Nov 16, 2017 | 2070 | | Stenbygaard 1993 Download |
Nov 16, 2017 | 2022 | | Minton 1999 Download |
Nov 16, 2017 | 2063 | | Johnston 2013 Download |
Nov 16, 2017 | 2067 | | Cancer Weekly April 2004 Download |
Nov 16, 2017 | 2129 | | Eagle 1949 Download |
Nov 16, 2017 | 2117 | | Greenblatt 1978 Download |
Nov 16, 2017 | 2019 | | Wiebe 1993 Download |
Nov 16, 2017 | 2165 | | Al-Matubsi 1998 Download |
Nov 16, 2017 | 2115 | | Ballard 1968 Download |
Nov 16, 2017 | 2079 | | Gupta Ch. 2 Download |
Nov 16, 2017 | 2144 | | Bonneterre 1985 Download |
Nov 16, 2017 | 2045 | | PDR 1999 Nolvadex Download |
Nov 16, 2017 | 2024 | | Hortobagyi New Eng. J. Med. 1998 Download |
Nov 16, 2017 | 2101 | | Merck Index 1996 Download |
Nov 16, 2017 | 2089 | | Vidal 1999 Download |
Nov 16, 2017 | 2123 | | Gupta Ch. 17 Download |
Nov 16, 2017 | 2093 | | Remington's Ch. 89 Download |
Nov 16, 2017 | 2066 | | Pharma Marketletter 2004 Download |
Nov 16, 2017 | 2077 | | Kuter 2012 Download |
Nov 16, 2017 | 2081 | | Remington's Ch. 75 Download |
Nov 16, 2017 | 2042 | | AACR Journals Online Download |
Nov 16, 2017 | 2050 | | Bratherton 1984 Download |
Nov 16, 2017 | 2155 | | Cristofanilli 2016 Download |
Nov 16, 2017 | 2015 | | Buzdar Clin. Oncol. 1998 Download |
Nov 16, 2017 | 2131 | | Yarinsky 1970 Download |
Nov 16, 2017 | 2138 | | Jonat 1996 Download |
Nov 16, 2017 | 2114 | | Zuidema 1994 Download |
Nov 16, 2017 | 2082 | | Aulton Ch. 1 Download |
Nov 16, 2017 | 2084 | | Remington's Ch. 84 Download |
Nov 16, 2017 | 2106 | | Ansel Ch. 14 Download |
Nov 16, 2017 | 2031 | | Robertson Clin. Ther. 2003 Download |
Nov 16, 2017 | 2120 | | Lifschitz 1999 Download |
Nov 16, 2017 | 2122 | | Chu 1960 Download |
Nov 16, 2017 | 2088 | | Baselga 2003 Download |
Nov 16, 2017 | 2139 | | Dombernowsky 1998 Download |
Nov 16, 2017 | 2164 | | Sibonga 1998 Download |
Nov 16, 2017 | 2146 | | Rose 1985 Download |
Nov 16, 2017 | 2069 | | Pyrhonen 1994 Download |
Nov 16, 2017 | 2062 | | Chia 2008 Download |
Nov 16, 2017 | 2145 | | Hortobagyi 1985 Download |
Nov 16, 2017 | 2035 | | Hortobagyi 1998 Download |
Nov 16, 2017 | 2023 | | Grese 1998 Download |
Nov 16, 2017 | 2002 | | Robertson Declaration Download |
Nov 16, 2017 | 2100 | | Gao 1998 Download |
Nov 16, 2017 | 2061 | | Bellmunt 1991 Download |
Nov 16, 2017 | 2104 | | Aulton Ch. 6 Download |
Nov 16, 2017 | 2109 | | Wade 1993 Download |
Nov 16, 2017 | 2001 | | Illum Declaration Download |
Nov 16, 2017 | 2003 | | Sawchuk Declaration Download |
Nov 16, 2017 | 2078 | | Buzdar 2006 Download |
Nov 16, 2017 | 2142 | | Goss 1998 Download |
Nov 16, 2017 | 2121 | | Lavy 1999 Download |
Nov 16, 2017 | 2157 | | Wright Ch. 4 Download |
Nov 16, 2017 | 2073 | | Robertson Eur. J. Cancer 2005 Download |
Nov 16, 2017 | 2092 | | Forrest Mylan Declaration Download |
Nov 16, 2017 | 2154 | | Robertson 2016 Download |
Nov 16, 2017 | 2150 | | Abrams 1999 Download |
Nov 16, 2017 | 2076 | | Agrawal 2009 Download |
Nov 16, 2017 | 2060 | | Robertson 2004 Download |
Nov 16, 2017 | 2057 | | Robertson SABCS 2014 Download |
Nov 16, 2017 | 2151 | | Jonat 2013 Download |
Nov 16, 2017 | 2072 | | Barrios 2012 Download |
Nov 16, 2017 | 2091 | | ABPI 1999-2000 Download |
Nov 16, 2017 | 2102 | | Ansel Ch. 10 Download |
Nov 16, 2017 | 2075 | | Vergote 2006 Download |
Nov 16, 2017 | 2010 | | Fornier 1999 Download |
Nov 16, 2017 | 2158 | | Strickley II 2000 Download |
Nov 16, 2017 | 2034 | | Labrie 1999 Download |
Nov 16, 2017 | 2086 | | Groves Ch. 2 Download |
Nov 16, 2017 | 2148 | | Muss 1990 Download |
Nov 16, 2017 | 2047 | | Rauschning 1994 Download |
Nov 16, 2017 | 2118 | | Litchfield 1961 Download |
Nov 16, 2017 | 2137 | | Buzdar 1997 Download |
Nov 16, 2017 | 2025 | | Masamura 1994 Download |
Nov 16, 2017 | 2052 | | Sweetana 1996 Download |
Nov 16, 2017 | 2097 | | Ansel Ch. 13 Download |
Nov 16, 2017 | 2095 | | Ansel Ch. 7 Download |
Nov 16, 2017 | 2065 | | Johnston 2004 Download |
Nov 16, 2017 | 2128 | | Skougaard 1966 Download |
Nov 16, 2017 | 2125 | | Affidavit of Internet Archive Download |
Nov 16, 2017 | 2156 | | Stenger 2017 Download |
Nov 16, 2017 | 2051 | | Cohen 1995 Download |
Nov 16, 2017 | 2080 | | Remington¿¿¿s Ch. 91 Download |
Nov 16, 2017 | 2085 | | Buzdar 1994 Download |
Nov 16, 2017 | 2098 | | Aulton Ch. 18 Download |
Nov 16, 2017 | 2087 | | Gupta Ch. 1 Download |
Nov 16, 2017 | 2059 | | Vergote 2003 Download |
Nov 16, 2017 | 2016 | | Howell 1992 Download |
Nov 16, 2017 | 2127 | | PDR 1999 Estrace Download |
Nov 16, 2017 | 2012 | | Hortobagyi Cancer Investigation 1998 Download |
Nov 16, 2017 | 2043 | | McLeskey Declaration Download |
Nov 16, 2017 | 2036 | | Robertson 1999 Download |
Nov 16, 2017 | 2055 | | Robertson 2009 Download |
Nov 16, 2017 | 2134 | | Lachman's 1986 Download |
Nov 16, 2017 | 2049 | | July 14 Trial Tr. Download |
Nov 16, 2017 | 2112 | | Strickley I 1999 Download |
Nov 16, 2017 | 2038 | | Dowsett 1995 Download |
Nov 16, 2017 | 2028 | | Howell 2002 Download |
Nov 16, 2017 | 2020 | | Jordan Supp. 1992 Download |
Nov 16, 2017 | 2083 | | Buzdar 2002 Download |
Nov 16, 2017 | 2099 | | Aulton Ch. 19 Download |
Nov 16, 2017 | 2090 | | Vidal 1997 Download |
Nov 16, 2017 | 2004 | | Di Leo 2010 Download |
Nov 16, 2017 | 2005 | | Di Leo 2014 Download |
Nov 16, 2017 | 2071 | | Robertson 2014 Download |
Nov 16, 2017 | 2113 | | Avis Ch. 3 Download |
Nov 16, 2017 | 2013 | | Johnston 1997 Download |
Nov 16, 2017 | 2029 | | Osborne 2002 Download |
Nov 16, 2017 | 2143 | | Hoffken 1992 Download |
Nov 16, 2017 | 2064 | | Robertson 2005 Download |
Nov 16, 2017 | 2153 | | Dowsett 1989 Download |
Nov 16, 2017 | 2141 | | Dowsett Clin. Cancer Res. 1995 Download |
Nov 16, 2017 | 2126 | | PDR 1999 Arimidex Download |
Nov 16, 2017 | 2033 | | Van de Velde 1996 Download |
Nov 16, 2017 | 2011 | | Jordan Supp. 1995 Download |
Nov 16, 2017 | 2021 | | Jordan 1992 Download |
Nov 16, 2017 | 2048 | | Thomas 1993 Download |
Nov 16, 2017 | 2026 | | Kelloff 1998 Download |
Nov 16, 2017 | 2132 | | Remington's Ch. 9 Download |
Nov 16, 2017 | 2094 | | Aulton Ch. 13 Download |
Nov 16, 2017 | 2161 | | Chatterjee 1993 Download |
Nov 16, 2017 | 2116 | | Hirano 1981 Download |
Nov 16, 2017 | 2107 | | Avis Ch. 2 Download |
Nov 16, 2017 | 2162 | | Applied Biopharmaceutics 1999 Download |
Nov 16, 2017 | 2018 | | Morrow 1993 Download |
Nov 16, 2017 | 2053 | | Fallowfield 2006 Download |
Nov 16, 2017 | 2133 | | Sawchuk Mylan Declaration Download |
Nov 16, 2017 | 2074 | | Clinical Practice Guidelines 2003 Download |
Nov 16, 2017 | 2103 | | Avis Ch. 4 Download |
Nov 16, 2017 | 2058 | | Ellis 2015 Download |
Nov 16, 2017 | 2046 | | PDR 1999 Femara Download |
Nov 16, 2017 | 2170 | | Rowland Ch. 13 Download |
Nov 16, 2017 | 2175 | | PTAB Order Download |
Nov 16, 2017 | 2166 | | Oleksowicz Mylan Declaration Download |
Nov 16, 2017 | 2172 | | FDA Guidance 1999 Download |
Nov 16, 2017 | 2167 | | Burgess Amneal Declaration Download |
Nov 16, 2017 | 2174 | | InnoPharma Petition Download |
Nov 16, 2017 | 2173 | | InnoPharma Decision Download |
Nov 16, 2017 | 2171 | | Shapiro 1965 Download |
Nov 16, 2017 | 2169 | | PDR 1999 Inderal LA Download |
Nov 16, 2017 | 8 | | Patent Owner's Preliminary Response to Petition for Inter Partes Review of U.S. Patent No. 8,466,139 Download |
Nov 16, 2017 | 2168 | | D'Agostino 1990 Download |
Dec 11, 2017 | 9 | | Decision - Denying Institution of Inter Partes Review Download |
Dec 11, 2017 | 3002 | | Amendment to the Claims, Patent Appl. No. 12/285,887 Download |
Jan 24, 2018 | 10 | | Petitioner's Refund Request Download |
Feb 2, 2018 | 11 | | Notice of Refund Download |